Don't have an account?
43% of women opt out of the breast care pathway when recommended for diagnostic breast follow-up1
The stressors of time, cost, and lack of comfort associated with the breast care pathway have led to a staggering number of women not getting the breast care they need. Let’s help you reach that 43%.
GE Healthcare’s contrast-enhanced mammography (CEM) system offers an excellent alternative for breast cancer detection. For your patients, CEM is an affordable, comfortable, and fast diagnostic option that allows them to continue their critical breast care. For your facility, CEM allows you to provide expanded and equitable patient access.
In addition to increasing patient access, our CEM offering, SenoBright™ HD, boasts high levels of sensitivity and specificity, for low false positives and unnecessary callbacks. With the introduction of Serena Bright™, clinicians can now perform biopsies using the same image guidance as the lesion identification, all on the same mammography system.
We believe personalized breast care means equal access to advanced imaging for all women. With CEM and CEM biopsy available through SenoBright and Serena Bright, you can ensure exceptional breast care to more women in your community.
1 According to The Breast Journal